VX1.DE · VERTEX PHARMAC. DL-,01
Germany · RS rating 67 · As of 2026-10-14
| Price | 436.35 EUR |
|---|---|
| 1-day change | -1.1% |
| RS rating (overall / 1M / 3M / 12M) | 67 / 40 / 61 / 69 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 34 / 33 / 34 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | +7.2% |
| Sales growth Q/Q | +11.6% |
| Distance from 52-week high | +9.1% |
| Market cap (USD) | $128.6B |